May 18, 2022
Mozart Therapeutics to Present on Novel CD8 T Cell Network at the 2022 Digestive Disease Week® (DDW) Conference
May 10, 2022
Mozart Therapeutics Presents Data at IMMUNOLOGY™ 2022 Highlighting Novel CD8 Treg Network in Celiac Disease and Other Autoimmune Diseases
March 21, 2022
Mozart Therapeutics Announces Appointment of Jan Beck as Chief Operating Officer
October 26, 2021
Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases